What question did this study set out to answer?

To assess the prevalence, user characteristics, and patterns of home mechanical ventilation provision for patients with chronic respiratory failure across Europe.

June 1, 2006Journal of the American Society of Nephrology

Protein Degradation by the Ubiquitin–Proteasome Pathway in Normal and Disease States

View Full Paper

Ask AI

Bookmark

To assess the prevalence, user characteristics, and patterns of home mechanical ventilation provision for patients with chronic respiratory failure across Europe.
Administered a standardized questionnaire on center characteristics, patient profiles, and equipment choices to identified home mechanical ventilation centers across 16 European countries.
Identified 483 centers managing 27,118 patients, with 329 centers completing the survey between July 2001 and June 2002 (response rate: 62%–79%), capturing data for up to 21,526 users.
Estimated the overall prevalence of home mechanical ventilation in Europe at 6.6 per 100,000 people, with national differences only partially explained by the year services were established.
Observed marked cross-country disparities in the diagnostic proportions of lung versus neuromuscular disorders and the frequency of tracheostomy utilization.
Identified distinct treatment durations by underlying condition: <1 year for lung disease users, 6–10 years for thoracic cage disorder users, and ≥6 years for neuromuscular disease users.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cross-sectional survey reveals wide variations in home mechanical ventilation practices in chronic respiratory failure, highlighting disparities in healthcare access and provision.

Cite This Study

Lecker et al. (2006) studied this question.

synapsesocial.com/papers/69dbcc1a5b363cdf1c835f01 https://doi.org/10.1681/asn.2006010083

View Full Paper

Ask AI

Bookmark

Implication

Cross-sectional survey reveals wide variations in home mechanical ventilation practices in chronic respiratory failure, highlighting disparities in healthcare access and provision.

Protein Degradation by the Ubiquitin–Proteasome Pathway in Normal and Disease States

Key Points

Discussion

Implication

Cite This Study

Protein Degradation by the Ubiquitin–Proteasome Pathway in Normal and Disease States

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider